Belimumab in childhood systemic lupus erythematosus: A review of available data

INTRODUCTION: Childhood systemic lupus erythematosus (cSLE) is a complex multisystem autoimmune disease. In 2019, belimumab was approved for the clinical treatment for cSLE, making it the only biological agent approved for cSLE children aged 5 and older in 60 years. OBJECTIVE: To review emerging evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Feng, Zheng, Ying, Chen, Xinying, Wen, Zhanfa, Xu, Youjia, Yang, Jinghua, Xu, Kaisi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363663/
https://www.ncbi.nlm.nih.gov/pubmed/35967351
http://dx.doi.org/10.3389/fimmu.2022.940416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363663/
https://www.ncbi.nlm.nih.gov/pubmed/35967351
http://dx.doi.org/10.3389/fimmu.2022.940416

Ejemplares similares